Logo

Jubilant Maps Affymetrix Probes Using Pathways Database

Aug 25, 2004

NEW YORK, Aug. 25 (GenomeWeb News) - Jubilant Biosys of Bangalore, India, said today that it has used PathArt, a database of over 900 signaling and metabolic pathways that are manually curated from literature, to map Affymetrix Probeset IDs.

 

"PathArt ... includes wide coverage on disease-specific pathways such as several cancers, arthritis, Alzheimer's, asthma, multiple sclerosis, Parkinson's, diabetes, and atherosclerosis," Sreenivas Devidas, Jubilant's vice president of business development and strategy said in a statement. "Researchers can map the data generated from Affymetrix chips directly onto pathways."

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.